On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Angiocrine Bioscience (United States)

InstitutionResearch output, impact & collaborations

Angiocrine Bioscience (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Angiocrine Bioscience (United States)?

ScholarIQrecord summary

Angiocrine Bioscience (United States) is a research organisation in San Diego, US. OpenAlex records 95 works and 3,669 citations for it. 47 researchers list it as their most recent affiliation.

How many works does Angiocrine Bioscience (United States) have?

ScholarIQindexed works

Angiocrine Bioscience (United States) has 95 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Angiocrine Bioscience (United States) have?

ScholarIQcitation count

Angiocrine Bioscience (United States) has 3,669 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Angiocrine Bioscience (United States)?

ScholarIQresearcher count

Angiocrine Bioscience (United States) has 47 researchers in the ScholarIQ index.

What is the average h-index at Angiocrine Bioscience (United States)?

ScholarIQavg h-index

Angiocrine Bioscience (United States) has an average h-index of 22 in OpenAlex.

What is the ROR of Angiocrine Bioscience (United States)?

ScholarIQror

The ROR for Angiocrine Bioscience (United States) is on the source record.

What is the OpenAlex record for Angiocrine Bioscience (United States)?

ScholarIQopenalex

The OpenAlex for Angiocrine Bioscience (United States) is on the source record.

Who are the most-cited researchers behind Angiocrine Bioscience (United States)?

ScholarIQtop researchers by citations
1
Jessie Wang · Atrial Fibrillation Management and Outcomes
108 works2,785 citations

What are the most-cited papers on Angiocrine Bioscience (United States)?

ScholarIQmost cited works
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis
Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury, Jessie Wang, Ming Chang, Donglu Zhang, Yan Song, Janice Pursley, Rebecca A. Boyd, Charles Frost
The Journal of Clinical Pharmacology. 2015285 CitationsOPEN ACCESS
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects
Charles Frost, Sunil Nepal, Jessie Wang, Alan Schuster, Wonkyung Byon, Rebecca A. Boyd, Zhigang Yu, Andrew Shenker, Yu Chen Barrett, Rogelio Mosqueda‐Garcia, Frank LaCreta
British Journal of Clinical Pharmacology. 2013283 CitationsOPEN ACCESS
Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
Vijay Upreti, Jessie Wang, Yu Chen Barrett, Wonkyung Byon, Rebecca A. Boyd, Janice Pursley, Frank LaCreta, Charles Frost
British Journal of Clinical Pharmacology. 2013271 CitationsOPEN ACCESS
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban
Ming Chang, Zhigang Yu, Andrew Shenker, Jessie Wang, Janice Pursley, Wonkyung Byon, Rebecca A. Boyd, Frank LaCreta, Charles Frost
The Journal of Clinical Pharmacology. 2015173 Citations
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study
Jeffrey S. Hyams, Sonia Thomas, Nathan Gotman, Yael Haberman, Rebekah Karns, Melanie Schirmer, Angela Mo, David R. Mack, Brendan Boyle, Anne M. Griffiths, Neal S. LeLeiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel R. Rosh, Robert N. Baldassano, Ashish Patel, Marian Pfefferkorn, Anthony Otley, Melvin B. Heyman, Joshua D. Noe, Maria Oliva‐Hemker, Paul A. Rufo, Jennifer Strople, David Ziring, Stephen L. Guthery, Boris Sudel, Keith Benkov, Prateek Wali, Dedrick E. Moulton, Jonathan Evans, Michael D. Kappelman, Miriam Marquis, Francisco Sylvester, Margaret H. Collins, Suresh Venkateswaran, Marla Dubinsky, Vin Tangpricha, Krista Spada, Bradley Saul, Jessie Wang, José Serrano, Kevin A. Hommel, Urko M. Marigorta, Greg Gibson, Ramnik J. Xavier, Subra Kugathasan, Thomas D. Walters, Lee A. Denson
The Lancet. 2019168 CitationsOPEN ACCESS

How much of the research on Angiocrine Bioscience (United States) is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
9%
Green
9%
Hybrid
18%
Bronze
36%
Closed
27%

Related on ScholarIQ

470M+ articles · 14-day free trial